He Liu, Xiao Yi
Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Aug 25;20(8):957-960.
Transanal total mesorectal excision (taTME) is a novel operative approach of the radical surgery for rectal cancer, and has been a hot topic in colorectal surgery for years. TaTME aims to solve some problems from previous TME, such as exposure of peripheral mid-lower rectal space, judge of distal cutting margin, and to carry out completely minimal invasive operation. According to the degree of completion of different surgical approach, taTME can be divided into laparoscopic assisted taTME (hybrid taTME) and fully through the anal approach to complete the taTME (pure taTME). At present, the anal operation equipment suitable for taTME is divided into two types: transnasal endoscopic microsurgical platform (TEM-TME) and transnasal minimally invasive surgical platform (TAMIS-TME). Until now, there is no consensus on the indications of taTME. For the treatment of some special circumstances resulting in surgical difficulties, such as low rectal cancer, male, obesity, patients with narrow pelvis, tumor depth of invasion to the surrounding tissue, tumor diameter >4 cm, tissue distortions by neoadjuvant therapy and refractory benign disease, taTME has potential advantages. As for contraindications, obstructive rectal cancer, emergency surgery and advanced tumors should currently be regarded as contraindications of taTME. It was reported that taTME was safe and feasible, and had a satisfactory short-term outcomes in several centers in China. The operation is characterized by good TME quality, distal margin and circumferential margins, especially in overweight patients with narrow pelvis. The surgical principle is the eternal cornerstone to ensure the radical tumor resection and the safety of patients. The laparoscopic technique is widely used in China and surgeons are going to be skilled with laparoscopic surgeries for low rectal cancers. This situation postpones the development of taTME. It is challenging and disputing to advocate taTME to replace transabdominal laparoscopic surgery for low rectal cancer at recent times. If we have suitable instrument to dissect the root nodes and have the evidence from several ongoing clinical trials, we hope taTME could become a pure transanal approach because of its unique cosmetic superiority, without any abdominal invasive incisions.
经肛门全直肠系膜切除术(taTME)是一种新型的直肠癌根治性手术方法,多年来一直是结直肠外科领域的热门话题。taTME旨在解决既往全直肠系膜切除术(TME)存在的一些问题,如直肠中下段周围间隙的暴露、远切缘的判断,并实现完全的微创手术。根据不同手术入路的完成程度,taTME可分为腹腔镜辅助taTME(混合taTME)和完全经肛门入路完成的taTME(纯taTME)。目前,适用于taTME的肛门手术设备分为两类:经鼻内镜显微手术平台(TEM-TME)和经鼻微创手术平台(TAMIS-TME)。到目前为止,taTME的适应证尚无共识。对于一些导致手术困难的特殊情况的治疗,如低位直肠癌、男性、肥胖、骨盆狭窄患者、肿瘤侵犯周围组织的深度、肿瘤直径>4 cm、新辅助治疗导致的组织变形以及难治性良性疾病,taTME具有潜在优势。至于禁忌证,目前应将梗阻性直肠癌、急诊手术和晚期肿瘤视为taTME的禁忌证。据报道,taTME在中国的几个中心是安全可行的,并且具有令人满意的短期疗效。该手术的特点是全直肠系膜切除质量好、远切缘和环周切缘满意,尤其是在超重且骨盆狭窄的患者中。手术原则是确保肿瘤根治性切除和患者安全的永恒基石。腹腔镜技术在中国广泛应用,外科医生对低位直肠癌的腹腔镜手术也越来越熟练。这种情况延缓了taTME的发展。近期主张用taTME替代低位直肠癌的经腹腹腔镜手术具有挑战性且存在争议。如果我们有合适的器械来解剖根部淋巴结并有正在进行的几项临床试验的证据,我们希望taTME因其独特的美容优势能够成为一种纯粹的经肛门入路,而无需任何腹部侵入性切口。